2000
DOI: 10.1007/s100169910070
|View full text |Cite
|
Sign up to set email alerts
|

Current Developments in Thoracoscopic Sympathectomy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
0

Year Published

2003
2003
2015
2015

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 31 publications
0
13
0
Order By: Relevance
“…Minimally invasive ETS has evolved to become a safe, effective, and reproducible treatment for facial blushing and hyperhidrosis (HH) of the hands, axilla, or face. Large published series have shown success rates of 71-100% following ETS with improved quality of life and treatment satisfaction of 93-95% [3,4]. However, no randomized trials have yet been performed to demonstrate the superiority of ETS over non-surgical treatments.…”
Section: Introductionmentioning
confidence: 98%
“…Minimally invasive ETS has evolved to become a safe, effective, and reproducible treatment for facial blushing and hyperhidrosis (HH) of the hands, axilla, or face. Large published series have shown success rates of 71-100% following ETS with improved quality of life and treatment satisfaction of 93-95% [3,4]. However, no randomized trials have yet been performed to demonstrate the superiority of ETS over non-surgical treatments.…”
Section: Introductionmentioning
confidence: 98%
“…Large series have shown success rates of 71-100% following conventional ETS for all forms of PHH with improved quality of life and treatment satisfaction of 93-95% [8,9]. Recent experience is obtained with even less-invasive surgery and single-port access techniques.…”
Section: Introductionmentioning
confidence: 99%
“…Though most case series reported immediate improvement in symptoms and healing of digital ulceration after ETS treatment for Raynaud's phenomenon, there remains controversy regarding the long-term efficacy of the procedure. 2 A recent longitudinal follow-up study of patients undergoing thoracoscopic sympathectomy found that one third of patients had a long-lasting benefit by 40 months of follow-up. 3 Recurrence of symptoms after ETS treatment for Raynaud's phenomenon is likely to be multi-factorial and may not reflect failure of the procedure.…”
Section: Discussionmentioning
confidence: 98%